<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03941522</url>
  </required_header>
  <id_info>
    <org_study_id>2019-4382</org_study_id>
    <nct_id>NCT03941522</nct_id>
  </id_info>
  <brief_title>Loop Ileostomy Closure as a 23-hour Stay Procedure, a Multi-center Randomized Controlled Trial</brief_title>
  <acronym>ILEO</acronym>
  <official_title>Loop Ileostomy Closure as a 23-hour Stay Procedure, a Multi-center Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Quebec-Universite Laval</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Quebec-Universite Laval</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety and feasibility of ileostomy closure
      performed in a 23 hours hospitalization setting, using a multi-center, open-label, randomized
      controlled trial comparing patients being hospitalized overnight (discharged on the day after
      surgery) to patients being hospitalized as per the current conventional care after ileostomy
      closure with both groups following a standardized enhanced recovery after surgery (ERAS)
      pathway specific to ileostomy closure. Primary outcome will be total length of hospital stay
      in days and secondary outcomes, measured at 30 days, will include readmission rate,
      postoperative complication rate minor and severe, postoperative ileus rate, postoperative
      surgical site infection rate and mortality rate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale :

      Loop ileostomy is defined by bringing a loop of small bowel out onto the surface of the skin
      to allow diversion of the fecal stream. It is a common procedure that is conjointly done with
      colorectal surgeries with the objective to protect intestinal anastomosis at high risk of
      leaking. Loop ileostomy closure is then performed in the months following the initial surgery
      when the anastomosis has healed. Often thought of as a simple procedure, it is still
      associated with a significant postoperative morbidity rate consisting mostly of postoperative
      ileus. In the CHU de Québec-Université Laval, patients are hospitalized for a median of five
      days until their bowels open up while no active care is given. This represents 645 days of
      hospitalization each year for Hôpital Saint-François d'Assise (HSFA), Hôtel-Dieu de Québec
      (HDQ) and Centre Hospitalier de l'Université Laval (CHUL). Hence, there is a clear need to
      determine if the investigator can improve the outcomes following ileostomy closure by
      applying a standardized enhanced recovery pathway specific to ileostomy closure to the point
      where the surgery can be performed in a twenty-three hours hospitalization setting.

      Objective :

      The purpose of this study is to assess the safety and feasibility of ileostomy closure
      performed in a 23 hours hospitalization setting, using a multi-center, open-label, randomized
      controlled trial comparing patients being hospitalized overnight (discharged on the day after
      surgery) to patients being hospitalized as per the current conventional care after ileostomy
      closure with both groups following a standardized enhanced recovery after surgery (ERAS)
      pathway specific to ileostomy closure. Primary outcome will be total length of hospital stay
      in days and secondary outcomes, measured at 30 days, will include readmission rate,
      postoperative complication rate minor and severe, postoperative ileus rate, postoperative
      surgical site infection rate and mortality rate.

      Hypothesis :

      The investigator believes patients randomized to the group 23-hour stay will have reduced
      total length of hospital stay compared to patients randomized to the group conventional
      hospitalization after ileostomy closure.

      Methods :

      Healthy adults (ASA I and II) undergoing elective ileostomy closure who consented to take
      part in the study will be enrolled in a standardized enhanced recovery pathway specific to
      ileostomy closure. Once surgery is completed, they will be randomized to either 23-hour stay
      or conventional hospitalization. Data on postoperative outcomes will be gathered
      prospectively until 30 days after surgery and will include total length of hospital stay in
      days, readmissions, postoperative complications, more precisely postoperative ileus and
      surgical site infections, as well as mortality.

      Clinical significance :

      If safety and feasibility of a fast discharge of patients is demonstrated by this study, it
      would then mean that patients could be discharged from hospital less than 24 hours after a
      loop ileostomy closure. It could potentially lower the consequences of a long hospital stay
      for patients, such as risks of nosocomial infections, thromboembolic events, and hospital
      acquired autonomy loss.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2019</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total length of hospital stay</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>The number of days spent in the hospital from the time of the surgery to the time of the discharge as well as any day spent in the hospital after any readmission in the 30 days following the ileostomy closure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Readmission rate</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Any hospitalisation after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complication rate</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Any complication after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative ileus rate</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Ileus necessitating installation of a nasogastric tube</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative surgical site infection rate</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Infection of the surgical site</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative mortality rate</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Death after the surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">168</enrollment>
  <condition>Ileostomy - Stoma</condition>
  <arm_group>
    <arm_group_label>Intervention group (23-hour stay)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to the group 23-hour stay will be discharged on the day after their surgery if they meet the discharge criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group (conventional hospitalization)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients randomized to the group conventional hospitalization will be hospitalized as per the current conventional care after ileostomy closure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Early discharge from hospital</intervention_name>
    <description>Patients randomized to the group 23-hour stay will be discharged on the day after their surgery if they meet the discharge criteria.</description>
    <arm_group_label>Intervention group (23-hour stay)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18 years and older

          -  Able to provide informed consent

          -  ASA I and II (American Society of Anesthesiologists)

          -  Staying less than 50 kilometers from a hospital after surgery

          -  Being accompanied by an adult able to assist the patient in his recovery and to
             intervene in case of an emergency for the first 48 hours after surgery

          -  No anastomotic leak proven on preoperative water soluble enema

        Exclusion Criteria:

          -  Language barrier or significant communication problem

          -  Immunosuppression

          -  Therapeutic anticoagulation

          -  Previous proctocolectomy

          -  Previous ileal pouch anal anastomosis

          -  Technical factors during surgery (conversion to midline laparotomy or other, at
             surgeon's discretion)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François Letarte, MD, MSc</last_name>
    <role>Study Director</role>
    <affiliation>CHU de Québec-Université Laval</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xavier Paré, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Québec-Université Laval</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Geneviève Morin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Québec-Université Laval</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xavier Paré, MD</last_name>
    <phone>418-684-7482</phone>
    <email>xavier.pare.2@ulaval.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Geneviève Morin, MD</last_name>
    <phone>418-641-9284</phone>
    <email>genevieve.morin.27@ulaval.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Saint-François d'Assise</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1L 3L5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Xavier Paré, MD</last_name>
      <phone>418-684-7482</phone>
      <email>xavier.pare.2@ulaval.ca</email>
    </contact>
    <contact_backup>
      <last_name>Geneviève Morin, MD</last_name>
      <phone>418-641-9284</phone>
      <email>genevieve.morin.27@ulaval.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Xavier Paré, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Geneviève Morin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôtel-Dieu de Québec</name>
      <address>
        <city>Québec</city>
        <zip>G1R 2J6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Xavier Paré, MD</last_name>
      <phone>418-684-7482</phone>
      <email>xavier.pare.2@ulaval.ca</email>
    </contact>
    <contact_backup>
      <last_name>Geneviève Morin, MD</last_name>
      <phone>418-641-9284</phone>
      <email>genevieve.morin.27@ulaval.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Xavier Paré, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Geneviève Morin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Hüser N, Michalski CW, Erkan M, Schuster T, Rosenberg R, Kleeff J, Friess H. Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery. Ann Surg. 2008 Jul;248(1):52-60. doi: 10.1097/SLA.0b013e318176bf65. Review.</citation>
    <PMID>18580207</PMID>
  </results_reference>
  <results_reference>
    <citation>Tan WS, Tang CL, Shi L, Eu KW. Meta-analysis of defunctioning stomas in low anterior resection for rectal cancer. Br J Surg. 2009 May;96(5):462-72. doi: 10.1002/bjs.6594. Review.</citation>
    <PMID>19358171</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen J, Wang DR, Yu HF, Zhao ZK, Wang LH, Li YK. Defunctioning stoma in low anterior resection for rectal cancer: a meta- analysis of five recent studies. Hepatogastroenterology. 2012 Sep;59(118):1828-31.</citation>
    <PMID>22193436</PMID>
  </results_reference>
  <results_reference>
    <citation>Koperna T. Cost-effectiveness of defunctioning stomas in low anterior resections for rectal cancer: a call for benchmarking. Arch Surg. 2003 Dec;138(12):1334-8; discussion 1339.</citation>
    <PMID>14662534</PMID>
  </results_reference>
  <results_reference>
    <citation>Wong KS, Remzi FH, Gorgun E, Arrigain S, Church JM, Preen M, Fazio VW. Loop ileostomy closure after restorative proctocolectomy: outcome in 1,504 patients. Dis Colon Rectum. 2005 Feb;48(2):243-50.</citation>
    <PMID>15714246</PMID>
  </results_reference>
  <results_reference>
    <citation>D'Haeninck A, Wolthuis AM, Penninckx F, D'Hondt M, D'Hoore A. Morbidity after closure of a defunctioning loop ileostomy. Acta Chir Belg. 2011 May-Jun;111(3):136-41.</citation>
    <PMID>21780519</PMID>
  </results_reference>
  <results_reference>
    <citation>Giannakopoulos GF, Veenhof AA, van der Peet DL, Sietses C, Meijerink WJ, Cuesta MA. Morbidity and complications of protective loop ileostomy. Colorectal Dis. 2009 Jul;11(6):609-12. doi: 10.1111/j.1463-1318.2008.01690.x. Epub 2008 Oct 1.</citation>
    <PMID>19175642</PMID>
  </results_reference>
  <results_reference>
    <citation>Chow A, Tilney HS, Paraskeva P, Jeyarajah S, Zacharakis E, Purkayastha S. The morbidity surrounding reversal of defunctioning ileostomies: a systematic review of 48 studies including 6,107 cases. Int J Colorectal Dis. 2009 Jun;24(6):711-23. doi: 10.1007/s00384-009-0660-z. Epub 2009 Feb 17. Review.</citation>
    <PMID>19221766</PMID>
  </results_reference>
  <results_reference>
    <citation>Löffler T, Rossion I, Bruckner T, Diener MK, Koch M, von Frankenberg M, Pochhammer J, Thomusch O, Kijak T, Simon T, Mihaljevic AL, Krüger M, Stein E, Prechtl G, Hodina R, Michal W, Strunk R, Henkel K, Bunse J, Jaschke G, Politt D, Heistermann HP, Fußer M, Lange C, Stamm A, Vosschulte A, Holzer R, Partecke LI, Burdzik E, Hug HM, Luntz SP, Kieser M, Büchler MW, Weitz J; HASTA Trial Group. HAnd Suture Versus STApling for Closure of Loop Ileostomy (HASTA Trial): results of a multicenter randomized trial (DRKS00000040). Ann Surg. 2012 Nov;256(5):828-35; discussion 835-6. doi: 10.1097/SLA.0b013e318272df97. Erratum in: Ann Surg. 2013 Mar;257(3):577.</citation>
    <PMID>23095628</PMID>
  </results_reference>
  <results_reference>
    <citation>Luglio G, Pendlimari R, Holubar SD, Cima RR, Nelson H. Loop ileostomy reversal after colon and rectal surgery: a single institutional 5-year experience in 944 patients. Arch Surg. 2011 Oct;146(10):1191-6. doi: 10.1001/archsurg.2011.234.</citation>
    <PMID>22006879</PMID>
  </results_reference>
  <results_reference>
    <citation>Hiranyakas A, Rather A, da Silva G, Weiss EG, Wexner SD. Loop ileostomy closure after laparoscopic versus open surgery: is there a difference? Surg Endosc. 2013 Jan;27(1):90-4. doi: 10.1007/s00464-012-2422-1. Epub 2012 Jun 30.</citation>
    <PMID>22752281</PMID>
  </results_reference>
  <results_reference>
    <citation>Mengual-Ballester M, García-Marín JA, Pellicer-Franco E, Guillén-Paredes MP, García-García ML, Cases-Baldó MJ, Aguayo-Albasini JL. Protective ileostomy: complications and mortality associated with its closure. Rev Esp Enferm Dig. 2012 Jul;104(7):350-4.</citation>
    <PMID>22849495</PMID>
  </results_reference>
  <results_reference>
    <citation>Gong J, Guo Z, Li Y, Gu L, Zhu W, Li J, Li N. Stapled vs hand suture closure of loop ileostomy: a meta-analysis. Colorectal Dis. 2013;15(10):e561-8. doi: 10.1111/codi.12388.</citation>
    <PMID>24033921</PMID>
  </results_reference>
  <results_reference>
    <citation>Peacock O, Bhalla A, Simpson JA, Gold S, Hurst NG, Speake WJ, Tierney GM, Lund JN. Twenty-three-hour stay loop ileostomy closures: a pilot study. Tech Coloproctol. 2013 Feb;17(1):45-9. doi: 10.1007/s10151-012-0880-z. Epub 2012 Aug 31.</citation>
    <PMID>22936588</PMID>
  </results_reference>
  <results_reference>
    <citation>Peacock O, Law CI, Collins PW, Speake WJ, Lund JN, Tierney GM. Closure of loop ileostomy: potentially a daycase procedure? Tech Coloproctol. 2011 Dec;15(4):431-7. doi: 10.1007/s10151-011-0781-6. Epub 2011 Oct 28.</citation>
    <PMID>22033543</PMID>
  </results_reference>
  <results_reference>
    <citation>Baraza W, Wild J, Barber W, Brown S. Postoperative management after loop ileostomy closure: are we keeping patients in hospital too long? Ann R Coll Surg Engl. 2010 Jan;92(1):51-5. doi: 10.1308/003588410X12518836439209.</citation>
    <PMID>20056062</PMID>
  </results_reference>
  <results_reference>
    <citation>Joh YG, Lindsetmo RO, Stulberg J, Obias V, Champagne B, Delaney CP. Standardized postoperative pathway: accelerating recovery after ileostomy closure. Dis Colon Rectum. 2008 Dec;51(12):1786-9. doi: 10.1007/s10350-008-9399-9. Epub 2008 Jun 24.</citation>
    <PMID>18575937</PMID>
  </results_reference>
  <results_reference>
    <citation>Kalady MF, Fields RC, Klein S, Nielsen KC, Mantyh CR, Ludwig KA. Loop ileostomy closure at an ambulatory surgery facility: a safe and cost-effective alternative to routine hospitalization. Dis Colon Rectum. 2003 Apr;46(4):486-90. Erratum in: Dis Colon Rectum. 2003 Jul;46(7):903. Nielson Karen C [corrected to Nielsen Karen C].</citation>
    <PMID>12682542</PMID>
  </results_reference>
  <results_reference>
    <citation>Gatt M, Reddy BS, Mainprize KS. Day-case stoma surgery: is it feasible? Surgeon. 2007 Jun;5(3):143-7.</citation>
    <PMID>17575667</PMID>
  </results_reference>
  <results_reference>
    <citation>Bhalla A, Peacock O, Tierney GM, Tou S, Hurst NG, Speake WJ, Williams JP, Lund JN. Day-case closure of ileostomy: feasible, safe and efficient. Colorectal Dis. 2015 Sep;17(9):820-3. doi: 10.1111/codi.12961.</citation>
    <PMID>25808587</PMID>
  </results_reference>
  <results_reference>
    <citation>Sajid MS, Craciunas L, Baig MK, Sains P. Systematic review and meta-analysis of published, randomized, controlled trials comparing suture anastomosis to stapled anastomosis for ileostomy closure. Tech Coloproctol. 2013 Dec;17(6):631-9. doi: 10.1007/s10151-013-1027-6. Epub 2013 May 17. Review.</citation>
    <PMID>23681301</PMID>
  </results_reference>
  <results_reference>
    <citation>Sajid MS, Bhatti MI, Miles WF. Systematic review and meta-analysis of published randomized controlled trials comparing purse-string vs conventional linear closure of the wound following ileostomy (stoma) closure. Gastroenterol Rep (Oxf). 2015 May;3(2):156-61. doi: 10.1093/gastro/gou038. Epub 2014 Jul 10. Review.</citation>
    <PMID>25011379</PMID>
  </results_reference>
  <results_reference>
    <citation>Bracey E, Chave H, Agombar A, Sleight S, Dukes S, Bryan S, Branagan G. Ileostomy closure in an enhanced recovery setting. Colorectal Dis. 2015 Oct;17(10):917-21. doi: 10.1111/codi.12989.</citation>
    <PMID>25950922</PMID>
  </results_reference>
  <results_reference>
    <citation>Adamina M, Kehlet H, Tomlinson GA, Senagore AJ, Delaney CP. Enhanced recovery pathways optimize health outcomes and resource utilization: a meta-analysis of randomized controlled trials in colorectal surgery. Surgery. 2011 Jun;149(6):830-40. doi: 10.1016/j.surg.2010.11.003. Epub 2011 Jan 14.</citation>
    <PMID>21236454</PMID>
  </results_reference>
  <results_reference>
    <citation>Man VC, Choi HK, Law WL, Foo DC. Morbidities after closure of ileostomy: analysis of risk factors. Int J Colorectal Dis. 2016 Jan;31(1):51-7. doi: 10.1007/s00384-015-2327-2. Epub 2015 Aug 6.</citation>
    <PMID>26245947</PMID>
  </results_reference>
  <results_reference>
    <citation>Keller DS, Swendseid B, Khan S, Delaney CP. Readmissions after ileostomy closure: cause to revisit a standardized enhanced recovery pathway? Am J Surg. 2014 Oct;208(4):650-5. doi: 10.1016/j.amjsurg.2014.05.003. Epub 2014 Jul 5.</citation>
    <PMID>25087854</PMID>
  </results_reference>
  <results_reference>
    <citation>Abrisqueta J, Abellan I, Luján J, Hernández Q, Parrilla P. Stimulation of the efferent limb before ileostomy closure: a randomized clinical trial. Dis Colon Rectum. 2014 Dec;57(12):1391-6. doi: 10.1097/DCR.0000000000000237.</citation>
    <PMID>25380005</PMID>
  </results_reference>
  <results_reference>
    <citation>Kaidar-Person O, Person B, Wexner SD. Complications of construction and closure of temporary loop ileostomy. J Am Coll Surg. 2005 Nov;201(5):759-73. Epub 2005 Sep 6. Review.</citation>
    <PMID>16256921</PMID>
  </results_reference>
  <results_reference>
    <citation>Rushworth GF, Megson IL. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol Ther. 2014 Feb;141(2):150-9. doi: 10.1016/j.pharmthera.2013.09.006. Epub 2013 Sep 28. Review.</citation>
    <PMID>24080471</PMID>
  </results_reference>
  <results_reference>
    <citation>Sabbagh C, Cosse C, Rebibo L, Hariz H, Dhahri A, Regimbeau JM. Identifying Patients Eligible for a Short Hospital Stay After Stoma Closure. J Invest Surg. 2018 Jun;31(3):168-172. doi: 10.1080/08941939.2017.1299818. Epub 2017 Mar 31.</citation>
    <PMID>28362132</PMID>
  </results_reference>
  <results_reference>
    <citation>Hou Y, Wang L, Yi D, Ding B, Yang Z, Li J, Chen X, Qiu Y, Wu G. N-acetylcysteine reduces inflammation in the small intestine by regulating redox, EGF and TLR4 signaling. Amino Acids. 2013 Sep;45(3):513-22. doi: 10.1007/s00726-012-1295-x. Epub 2012 Apr 25.</citation>
    <PMID>22532030</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang Q, Hou Y, Yi D, Wang L, Ding B, Chen X, Long M, Liu Y, Wu G. Protective effects of N-acetylcysteine on acetic acid-induced colitis in a porcine model. BMC Gastroenterol. 2013 Aug 30;13:133. doi: 10.1186/1471-230X-13-133.</citation>
    <PMID>24001404</PMID>
  </results_reference>
  <results_reference>
    <citation>Fohl AL, Johnson CE, Cober MP. Stability of extemporaneously prepared acetylcysteine 1% and 10% solutions for treatment of meconium ileus. Am J Health Syst Pharm. 2011 Jan 1;68(1):69-72. doi: 10.2146/ajhp100214.</citation>
    <PMID>21164069</PMID>
  </results_reference>
  <results_reference>
    <citation>Bokey EL, Chapuis PH, Fung C, Hughes WJ, Koorey SG, Brewer D, Newland RC. Postoperative morbidity and mortality following resection of the colon and rectum for cancer. Dis Colon Rectum. 1995 May;38(5):480-6; discussion 486-7.</citation>
    <PMID>7736878</PMID>
  </results_reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 6, 2019</study_first_submitted>
  <study_first_submitted_qc>May 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2019</study_first_posted>
  <last_update_submitted>June 11, 2019</last_update_submitted>
  <last_update_submitted_qc>June 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>loop ileostomy</keyword>
  <keyword>diversion ileostomy</keyword>
  <keyword>ileostomy closure</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 6, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/22/NCT03941522/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

